chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Lip oedema, Oedema peripheral, Pruritus, Urticaria
Clinical narrative: Narrative: 36 y/o M received the Moderna COVID booster on 12/28/21. He  presented to ED on 1/9/22 w/ urticaria and pruritis x 1 day; received  methylprednisolone 125mg IV, diphenhydramine 25mg 1M, and topical  hydrocortisone cream in the ED and discharged home w/ prednisone,  diphenhydramine, and hydrocortisone cream. Symptoms initially improved then  worsened again w edema to hands and lip. He presented to derm clinic then to  ED and received methylprednisolone 125mg IV, famotidine, and diphenhydramine discharged home w/ cetirizine, hydroxyzine, and medrol dose pack with allergy  clinic consult f/u placed. Ongoing assessement to determine potential symptom  triggers-resuming regular chronic meds one at a time starting with  sertraline>quetaipine>prazosine. Per ID consult, pt had no rxn to first2 doses but cannot exclude Moderna booster as a possible cause of allergic rxn.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Incomplete course of vaccination
Clinical narrative: Narrative:
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient tested positive for COVID-19 and was hospitalized despite of being fully vaccinated with two doses of Pfizer and receiving a booster from Pfizer on 09/20/2021.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient tested positive for COVID-19 and was hospitalized despite full vaccination. Pt received Pfizer (2 doses) last one on 02/16/2021. No booster dose was received.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Diarrhoea, Fatigue, Headache
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/22, Pfizer,  dose #1 04/12, Pfizer, dose #2 10/27, Pfizer, dose #3 12/27 COVID swab, result:  detected 12/25 pt cc: diarrhea, sore throat, fatigue, fever, exposure: unknown  12/27 pt admit ED cc: myalgia, fatigue, sore throat, chills, headache dx: covid 19  LOS: 1 day 1/1 clinically resolved
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/22, Pfizer,  dose #1 04/12, Pfizer, dose #2 10/27, Pfizer, dose #3 12/27 COVID swab, result:  detected 12/25 pt cc: diarrhea, sore throat, fatigue, fever, exposure: unknown  12/27 pt admit ED cc: myalgia, fatigue, sore throat, chills, headache dx: covid 19  LOS: 1 day 1/1 clinically resolved
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/27, Pfizer,  dose #1 05/18, Pfizer, dose #2 12/16 COVID swab, result: not detected 1/10  COVID swab, result: detected 1/10 pt cc: exposure: unknown
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Headache, Inappropriate schedule of product administration
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/31, Pfizer, dose #1 04/21, Pfizer, dose #2 11/10, Pfizer #3 12/27 COVID swab, result: detected 12/25 pt cc: cough, diarrhea, headache, rhinorrhea, sore throat exposure: unknown 12/30 clinically resolved
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/31, Pfizer, dose #1 04/21, Pfizer, dose #2 11/10, Pfizer #3 12/27 COVID swab, result: detected 12/25 pt cc: cough, diarrhea, headache, rhinorrhea, sore throat exposure: unknown 12/30 clinically resolved
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Acute kidney injury, Blood fibrinogen increased, Brain natriuretic peptide, C-reactive protein normal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/23. Pfizer, dose #1 03/16, Pfizer, dose 32 08/30, Pfizer, dose #3 12/20 CXR impression: Stable examination. No acute cardiopulmonary pathology identified at present. 12/27 CXR impression: No focal airspace opacity. 12/27 COVID swab, result: detected 12/26 pt cc: diarrhea, myalgias, rhinorrhea, exposure: unknown 1/1 pt admit to Clinic cc: "crohn's flare up" abd pain x 3 days" DX: Covid infection, cute kidney injury LOS: 8 DAYS 1/1 BNP: 14,4 1/1 SARC-COV-2 IGG: 0.01 1/1 FIBRINOGEN: 485 1/1 DDIMER: 0.68 1/1 CRP: 0.446 1/1 PROCALCITONIN: <0.05 1/1 SARS-COV-2 Variant Sequencing: pending 1/1 CT ABD/PEL W/O impression: 1. No acute abnormality in the abdomen and pelvis. No evidence of bowel inflammation or obstruction. Colonic diverticulosis. Bilateral nonobstructing renal calculi. 2. Some minimal patchy groundglass opacity in the right lower lobe which could be inflammatory or postinflammatory. 1/1 CXR impression: No radiographic evidence of acute cardiopulmonary disease. Please note that early/mild COVID-19 pneumonia may be radiographically occult, and groundglass opacities seen on same day comparison CT abdomen and pelvis are not apparent on this examination. 1/2 FIBRINOGEN: 465 1/2 DDIMER:0.53 1/2 ESR: 34 1/3 FIBRINOGEN: 391 1/3 DDIMER: 0.39 1/3 ESR: 35 1/4 ESR: 11 1/5 FIBRINOGEN: 360 1/5 DDIMER: 0.39
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray normal, Computerised tomogram abdomen abnormal, Condition aggravated, Crohn's disease
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/23. Pfizer, dose #1 03/16, Pfizer, dose 32 08/30, Pfizer, dose #3 12/20 CXR impression: Stable examination. No acute cardiopulmonary pathology identified at present. 12/27 CXR impression: No focal airspace opacity. 12/27 COVID swab, result: detected 12/26 pt cc: diarrhea, myalgias, rhinorrhea, exposure: unknown 1/1 pt admit to Clinic cc: "crohn's flare up" abd pain x 3 days" DX: Covid infection, cute kidney injury LOS: 8 DAYS 1/1 BNP: 14,4 1/1 SARC-COV-2 IGG: 0.01 1/1 FIBRINOGEN: 485 1/1 DDIMER: 0.68 1/1 CRP: 0.446 1/1 PROCALCITONIN: <0.05 1/1 SARS-COV-2 Variant Sequencing: pending 1/1 CT ABD/PEL W/O impression: 1. No acute abnormality in the abdomen and pelvis. No evidence of bowel inflammation or obstruction. Colonic diverticulosis. Bilateral nonobstructing renal calculi. 2. Some minimal patchy groundglass opacity in the right lower lobe which could be inflammatory or postinflammatory. 1/1 CXR impression: No radiographic evidence of acute cardiopulmonary disease. Please note that early/mild COVID-19 pneumonia may be radiographically occult, and groundglass opacities seen on same day comparison CT abdomen and pelvis are not apparent on this examination. 1/2 FIBRINOGEN: 465 1/2 DDIMER:0.53 1/2 ESR: 34 1/3 FIBRINOGEN: 391 1/3 DDIMER: 0.39 1/3 ESR: 35 1/4 ESR: 11 1/5 FIBRINOGEN: 360 1/5 DDIMER: 0.39
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Diverticulum intestinal, Fibrin D dimer, Lung opacity, Myalgia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/23. Pfizer, dose #1 03/16, Pfizer, dose 32 08/30, Pfizer, dose #3 12/20 CXR impression: Stable examination. No acute cardiopulmonary pathology identified at present. 12/27 CXR impression: No focal airspace opacity. 12/27 COVID swab, result: detected 12/26 pt cc: diarrhea, myalgias, rhinorrhea, exposure: unknown 1/1 pt admit to Clinic cc: "crohn's flare up" abd pain x 3 days" DX: Covid infection, cute kidney injury LOS: 8 DAYS 1/1 BNP: 14,4 1/1 SARC-COV-2 IGG: 0.01 1/1 FIBRINOGEN: 485 1/1 DDIMER: 0.68 1/1 CRP: 0.446 1/1 PROCALCITONIN: <0.05 1/1 SARS-COV-2 Variant Sequencing: pending 1/1 CT ABD/PEL W/O impression: 1. No acute abnormality in the abdomen and pelvis. No evidence of bowel inflammation or obstruction. Colonic diverticulosis. Bilateral nonobstructing renal calculi. 2. Some minimal patchy groundglass opacity in the right lower lobe which could be inflammatory or postinflammatory. 1/1 CXR impression: No radiographic evidence of acute cardiopulmonary disease. Please note that early/mild COVID-19 pneumonia may be radiographically occult, and groundglass opacities seen on same day comparison CT abdomen and pelvis are not apparent on this examination. 1/2 FIBRINOGEN: 465 1/2 DDIMER:0.53 1/2 ESR: 34 1/3 FIBRINOGEN: 391 1/3 DDIMER: 0.39 1/3 ESR: 35 1/4 ESR: 11 1/5 FIBRINOGEN: 360 1/5 DDIMER: 0.39
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nephrolithiasis, Procalcitonin, Red blood cell sedimentation rate increased, Rhinorrhoea, SARS-CoV-2 antibody test
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/23. Pfizer, dose #1 03/16, Pfizer, dose 32 08/30, Pfizer, dose #3 12/20 CXR impression: Stable examination. No acute cardiopulmonary pathology identified at present. 12/27 CXR impression: No focal airspace opacity. 12/27 COVID swab, result: detected 12/26 pt cc: diarrhea, myalgias, rhinorrhea, exposure: unknown 1/1 pt admit to Clinic cc: "crohn's flare up" abd pain x 3 days" DX: Covid infection, cute kidney injury LOS: 8 DAYS 1/1 BNP: 14,4 1/1 SARC-COV-2 IGG: 0.01 1/1 FIBRINOGEN: 485 1/1 DDIMER: 0.68 1/1 CRP: 0.446 1/1 PROCALCITONIN: <0.05 1/1 SARS-COV-2 Variant Sequencing: pending 1/1 CT ABD/PEL W/O impression: 1. No acute abnormality in the abdomen and pelvis. No evidence of bowel inflammation or obstruction. Colonic diverticulosis. Bilateral nonobstructing renal calculi. 2. Some minimal patchy groundglass opacity in the right lower lobe which could be inflammatory or postinflammatory. 1/1 CXR impression: No radiographic evidence of acute cardiopulmonary disease. Please note that early/mild COVID-19 pneumonia may be radiographically occult, and groundglass opacities seen on same day comparison CT abdomen and pelvis are not apparent on this examination. 1/2 FIBRINOGEN: 465 1/2 DDIMER:0.53 1/2 ESR: 34 1/3 FIBRINOGEN: 391 1/3 DDIMER: 0.39 1/3 ESR: 35 1/4 ESR: 11 1/5 FIBRINOGEN: 360 1/5 DDIMER: 0.39
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/23. Pfizer, dose #1 03/16, Pfizer, dose 32 08/30, Pfizer, dose #3 12/20 CXR impression: Stable examination. No acute cardiopulmonary pathology identified at present. 12/27 CXR impression: No focal airspace opacity. 12/27 COVID swab, result: detected 12/26 pt cc: diarrhea, myalgias, rhinorrhea, exposure: unknown 1/1 pt admit to Clinic cc: "crohn's flare up" abd pain x 3 days" DX: Covid infection, cute kidney injury LOS: 8 DAYS 1/1 BNP: 14,4 1/1 SARC-COV-2 IGG: 0.01 1/1 FIBRINOGEN: 485 1/1 DDIMER: 0.68 1/1 CRP: 0.446 1/1 PROCALCITONIN: <0.05 1/1 SARS-COV-2 Variant Sequencing: pending 1/1 CT ABD/PEL W/O impression: 1. No acute abnormality in the abdomen and pelvis. No evidence of bowel inflammation or obstruction. Colonic diverticulosis. Bilateral nonobstructing renal calculi. 2. Some minimal patchy groundglass opacity in the right lower lobe which could be inflammatory or postinflammatory. 1/1 CXR impression: No radiographic evidence of acute cardiopulmonary disease. Please note that early/mild COVID-19 pneumonia may be radiographically occult, and groundglass opacities seen on same day comparison CT abdomen and pelvis are not apparent on this examination. 1/2 FIBRINOGEN: 465 1/2 DDIMER:0.53 1/2 ESR: 34 1/3 FIBRINOGEN: 391 1/3 DDIMER: 0.39 1/3 ESR: 35 1/4 ESR: 11 1/5 FIBRINOGEN: 360 1/5 DDIMER: 0.39
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injection site hypoaesthesia, Injection site paraesthesia, Neck pain, Pain
Clinical narrative: Narrative:  PT STILL HAVING PAIN ISSUES 7 MONTHS POST INJECTION. NO COMPLICATIONS WERE NOTED WITH EITHER VACCINE ADMINISTRATION. PT COMPLAINS OF PAIN, NUMBNESS, AND TINGLING THAT RADIATES UP HIS NECK ORIGINATING FROM VACCINATION SITE.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia, Vaccination site pain
Clinical narrative: Narrative:  PT STILL HAVING PAIN ISSUES 7 MONTHS POST INJECTION. NO COMPLICATIONS WERE NOTED WITH EITHER VACCINE ADMINISTRATION. PT COMPLAINS OF PAIN, NUMBNESS, AND TINGLING THAT RADIATES UP HIS NECK ORIGINATING FROM VACCINATION SITE.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Eye pain, Eyelid rash, Rash
Clinical narrative: eye pain, redness and rash around left eye and left side of  forehead and scalp  Narrative: Employee seen and following up with  Ophthalmology. Seen Ophthalmology on 11/22/2021.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt under care of Hospice for several months before vaccine was administered
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging head, Unevaluable event
Clinical narrative: Narrative:
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Guillain-Barre syndrome
Clinical narrative: Narrative: Pt did not get COIVD-19 vaccine. Pt has hx of Guillian Barre two times prior post vaccination--will not get COVID or influenza vaccine in the future so it is listed as allergy.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient tested positive for COVID-19 and was hospitalized despite full vaccination (received 2 doses of Pfizer [04/20/2021; 05/11/2021] no booster received up to date). Patient was initially positive on 12/30/20021 but was only admitted on 01/04/2022 due to worsening symptoms. Patient was re-tested on 1/17/2022 and remained COVID-19 positive.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cough, Dyspnoea, Hypoxia
Clinical narrative: Narrative:  PATIENT WAS VACCINATED IN TIMELY MANNER 1/24/21 AND 2/18/21. PATIENT CALLED EMS 10/4 REPORTING A WORSENING COUGH AND DIFFICULTY BREATHING. HE WAS FOUND TO BE SATTING IN UPPER 80S TO 90S--PATIENT WAS PUT ON O2 AND TRANSPORTED TO HOSPITAL. PT HOSPITALIZED FOR HYPOXIA, COVID PNEUMONIA, AND POSSIBLE COPD EXACERBATION.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Narrative:  PATIENT WAS VACCINATED IN TIMELY MANNER 1/24/21 AND 2/18/21. PATIENT CALLED EMS 10/4 REPORTING A WORSENING COUGH AND DIFFICULTY BREATHING. HE WAS FOUND TO BE SATTING IN UPPER 80S TO 90S--PATIENT WAS PUT ON O2 AND TRANSPORTED TO HOSPITAL. PT HOSPITALIZED FOR HYPOXIA, COVID PNEUMONIA, AND POSSIBLE COPD EXACERBATION.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  83yo male patient died on 1/8/2022 at home in home hospice care. with the following: Medical Hx: Alzheimer's dementia, vascular dementia, moderate valvular aortic stenosis, HTN, HLD, BPH, iron deficiency anemia, peripheral vascular disease, esophagitis, Rectal cancer s/p Lower Ant. Resection (2003) and ileostomy closure (2004), LUL carcinoma s/p wedges 2007 then lobectomy 2009. Surgical Hx: Lower Ant. Resection 2003, ileostomy closure 2004, Fem-Fem bypass 2006, LUL VATS Wedge 2007 and LUL Lobectomy 2009, OU IOLs 2021 Pt had received covid vaccines at nonfacility site on 7/14/21 & 8/13/21. This pt's death appears to not be related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Rash, SARS-CoV-2 test positive
Clinical narrative: Narrative: Generalized rash to torso and legs once after second dose of covid-19 vaccine. Reports rash full body 2nd episode post COVID- 19 infection (positive on 1/6/2022).
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Veteran tested positive for COVID-19 and was hospitalized despite full vaccination. Pt received PFIZER (2 doses) last one on 02/16/2021. No booster was received.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, COVID-19 pneumonia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  PT WAS VACCINATED IN A TIMELY MANNER 2/11 AND  3/11 WITH MODERNA MRNA VACCINE OUTSIDE OF FACILITY. PT WAS  ADMITTED 10-9 AND HAD POSITIVE TEST AT THAT TIME. PT HAD  A LENGTHY, BUT UNEVENTFUL HOSPITAL STAY DUE TO COVID  PNEUMONIA RESULTING IN EXTREME WEAKNESS. HE REMAINED ON  RA ENTIRE STAY. HE WAS TREATED WITH REMDESIVIR, RECOVERED,  AND WAS DISCHARGED TO FACILITY FOR REHABILITATION.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Hypotension, Oxygen saturation decreased
Clinical narrative: Developed chills, low BP, low 02 after Pfizer COVID vaccine. Did not receive vaccination at clinic. Per patient report.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Pt was vaccinated in a timely manner in Feb/Mar 2021 but was hospitalized due to positive COVID test 8/20/21--admitted due to weakness, experienced hypoxia, improved and was later discharged.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Laboratory test abnormal, Pulmonary congestion, Tachycardia
Clinical narrative: Narrative:  PATIENT WAS VACCINATED IN A TIMELY MANNER IN JAN/FEB 2021 WITH PFIZER. PT WAS ADMITTED 8-17-21 AFTER PRESENTING TO ER WITH COUGH, CHEST CONGESTION, DIARRHEA AND TACHYCARDIA. PATIENT WAS PROVIDED O2 BRIEFLY FOR TACHYCARDIA AND FOR COMFORT WHILE SLEEPING (NO CPAP MACHINES AVAILABLE)
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Neck pain, Pain, Paraesthesia, Vaccination site hypoaesthesia
Clinical narrative: Narrative:  PT STILL HAVING PAIN ISSUES 7 MONTHS POST INJECTION. NO COMPLICATIONS WERE NOTED WITH EITHER VACCINE ADMINISTRATION. PT COMPLAINS OF PAIN, NUMBNESS, AND TINGLING THAT RADIATES UP HIS NECK ORIGINATING FROM VACCINATION SITE.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site paraesthesia
Clinical narrative: Narrative:  PT STILL HAVING PAIN ISSUES 7 MONTHS POST INJECTION. NO COMPLICATIONS WERE NOTED WITH EITHER VACCINE ADMINISTRATION. PT COMPLAINS OF PAIN, NUMBNESS, AND TINGLING THAT RADIATES UP HIS NECK ORIGINATING FROM VACCINATION SITE.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Decreased appetite, Diarrhoea, Fatigue
Clinical narrative: Narrative:  PATIENT WAS VACCINATED IN TIMELY MANNER 3-12-21 AND 4-2-21 AND TESTED POSITIVE FOR COVID 9-28-21. PATIENT WAS ADMITTED 10-4-21 AFTER ED VISIT PRESENTING WITH FEVER, CHILLS, FATIGUE, PRODUCTIVE COUGH, DIARRHEA, LOSS OF APPETITE. PATIENT WAS MILDLY HYPOXIC--WAS ON 2 L O2 AND DEXAMETHASONE.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Productive cough, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  PATIENT WAS VACCINATED IN TIMELY MANNER 3-12-21 AND 4-2-21 AND TESTED POSITIVE FOR COVID 9-28-21. PATIENT WAS ADMITTED 10-4-21 AFTER ED VISIT PRESENTING WITH FEVER, CHILLS, FATIGUE, PRODUCTIVE COUGH, DIARRHEA, LOSS OF APPETITE. PATIENT WAS MILDLY HYPOXIC--WAS ON 2 L O2 AND DEXAMETHASONE.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Cough, Dyspnoea, Hypoxia
Clinical narrative: Narrative: Completed Pfizer vaccination series in January 2021. Had 3 days of coughing before presenting to the hospital and tested positive 8/19/21. Treated for hypoxic pneumonia with dexamethasone and as needed oxygen. Discharged home 8/23/21. Re-admitted for fever, coughing, and shortness of breath 8/24/21 and diagnosed with super-imposed bacterial pneumonia. Continued dexamethasone treatment and added enoxaparin. Discharged home 8/27/21.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Pneumonia bacterial, Pyrexia, SARS-CoV-2 test positive, Superinfection
Clinical narrative: Narrative: Completed Pfizer vaccination series in January 2021. Had 3 days of coughing before presenting to the hospital and tested positive 8/19/21. Treated for hypoxic pneumonia with dexamethasone and as needed oxygen. Discharged home 8/23/21. Re-admitted for fever, coughing, and shortness of breath 8/24/21 and diagnosed with super-imposed bacterial pneumonia. Continued dexamethasone treatment and added enoxaparin. Discharged home 8/27/21.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, Oxygen saturation decreased, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient completed Moderna COVID series in February 2021 and residing in Nursing Home. Had congestion and low O2 sat. Taken to hospital and tested positive for COVID-19 on 8/22/21 but not admitted. Sent back to nursing facility with oral dexamethasone and require more oxygen. Admitted to  hospital 8/23 and treated with remdesivir, dexamethasone, and enoxaparin. Discharged back to nursing home 8/26/21.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Transient ischaemic attack
Clinical narrative: Narrative: reported TIA 2-3 days after vaccine administration
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Narrative:
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Blood fibrinogen increased, Blood lactate dehydrogenase increased, C-reactive protein increased, COVID-19, Chest X-ray abnormal
Clinical narrative: Narrative:  Patient discharged to home on 10/24/21.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Lung opacity, Procalcitonin normal, Pulmonary congestion, Pulmonary mass
Clinical narrative: Narrative:  Patient discharged to home on 10/24/21.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, SARS-CoV-2 test positive, Serum ferritin increased
Clinical narrative: Narrative:  Patient discharged to home on 10/24/21.
Age: 56.0
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia, Rash
Clinical narrative: Narrative: 23-year-old male with a PMH of ADHD who reported to his primary care provider signs symptoms of headache, low grade fever of 100. IF, headache and rash on both arms a day after receiving J&J COVID-19 vaccine. The patient took 2 tablets of Tylenol and was advised by the provider to take diphenhydramine and continue support care. The patient declined getting tested for COVID 19 and agreed with the treatment plan. No other information available after that phone encounter
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy
Clinical narrative: Narrative: doses of prednisone to treat bells palsy may have masked reaction to second dose of COVID vaccine
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  PATIENT WAS VACCINATED IN TIMELY MANNER 1/15 AND 2/5/21 WITH PFIZER AND TESTED POSITIVE FOR COVID 8-30-21.  PATIENT WAS HOSPITALIZED 9/2/21 AND WAS TREATED FOR HYPOXIA--HE IMPROVED AND WAS DISCHARGED.
Age: 72.0
Sex: M
Vaccine: PPV
Symptoms: Injection site pruritus
Clinical narrative: Narrative:  a71yo male with PMH of Tobacco Use, DJD, Vitamin D deficiency, Cervical Spondylosis without Myelopathy, GERD. Cough, Rectal Bleeding, Low Back Pain, General Weakness, Hypertension, Hyperlipidemia, Asymptomatic Carotid Artery Stenosis, Chronic gingivitis, BPH, Osteoarthritis, Pain of LT Shoulder Joint and ED. Per vaccine administering staff RN documentation; He received Pneumovax 0.5ml IM in left shoulder on September 16, 2021 and 10 to 15 minutes post vaccination, had itching at the injection site. The physician in charge was notified, oral Benadryl 25mg was ordered, administered and was tolerated well
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  PATIENT WAS VACCINATED IN TIMELY MANNER FEB 1, AND FEB 22, 2021. PATIENT TESTED POSITIVE FOR COVID 8-30-21 AFTER PRESENTING IN ED WITH GENERALIZED WEAKNESS. PATIENT WAS HOSPITALIZED AND IMPROVED, LATER DISCHARGED TO HOME.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Electrocardiogram normal, Troponin normal
Clinical narrative: Narrative:  63yo male who presented to clinic to receive his 3rd COVID vaccine booster. He stated that on minute 12 he started to feel a "tightness" in his chest, which resolved after EMS gave him 324mg of chewable aspirin. Troponin was checked and was found to be negative x 2. His EKG showed no changes. Chest pain thought very unlikely to be an adverse reaction to COVID vaccine.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Diarrhoea, Dyspnoea, Myalgia, Nausea
Clinical narrative: Narrative: Patient presented to the ED after testing positive for COVID 9/28 with GI symptoms of nausea, vomiting, diarrhea, as well as mild shortness of breath and muscle aches. He was admitted 10/1. He was admitted primarily for rhabdomyolysis in the presence of COVID.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Rhabdomyolysis, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Narrative: Patient presented to the ED after testing positive for COVID 9/28 with GI symptoms of nausea, vomiting, diarrhea, as well as mild shortness of breath and muscle aches. He was admitted 10/1. He was admitted primarily for rhabdomyolysis in the presence of COVID.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Hypoxia, Myalgia, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient was vaccinated in a timely manner with pfizer mrna vaccine on 2/6 and 2/27. Pt was admitted on 10-23 after testing positive for covid 10-21. Pt presented with hypoxia, dyspnea, and myalgia. Pt was treated, improved and discharged,
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Rash, Urticaria
Clinical narrative: Narrative:  Patient received second COVID vaccine on 9/9/21 (first COVID  vaccine administered 2/10/21). Patient also received influenza vaccine 10/26/21.  Immunizations were administered in left deltoid. Patient developed rash/hives on  right arm and back. No new medications noted.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Feeling cold
Clinical narrative: Narrative: Per nurse's report, patient complained of felling "tired, weak, and cold" for 2-3 days after receiving Moderna COVID booster
Age: 78.0
Sex: M
Vaccine: FLU4
Symptoms: Rash, Urticaria
Clinical narrative: Narrative:  Influenza vaccine was administered in left deltoid. Patient developed rash and hives involving right arm and back. Patient denied any new medications or OTC products.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia
Clinical narrative: Narrative: Pt experience "extreme weakness" after 3rd dose of COVID vaccine (Moderna). Of note, no reported intolerance or ADRs for the first 2 doses.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, COVID-19 pneumonia, SARS-CoV-2 test positive
Clinical narrative: Narrative: PATIENT WAS VACCINATED IN A TIMELY MANNER 2/11 AND 3/11 WITH MODERNA MRNA VACCINE OUTSIDE. PT WAS ADMITTED 10-9 AND HAD POSITIVE BIOFIRE AT THAT TIME. PATIENT HAD A LENGTHY, BUT UNEVENTFUL HOSPITAL STAY DUE TO COVID PNEUMONIA RESULTING IN EXTREME WEAKNESS. HE REMAINED ON RA ENTIRE STAY. HE WAS TREATED WITH REMDESIVIR, RECOVERED, AND WAS DISCHARGED FOR REHABILITATION.
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Pyrexia, Somnolence, Tremor
Clinical narrative: Narrative: Pt is shaking, sleepy, not eating-stating not hungry with low grade fever of 99.8. Pt received moderna COVID vaccine yesterday
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chronic obstructive pulmonary disease, Dyspnoea, Productive cough
Clinical narrative: Narrative:  PATIENT WAS IMMUNIZED IN TIMELY MANNER WITH PFIZER MRNA VACCINE ON 2/28 AND 3/21 RESPECTIVELY.  PATIENT PRESENTED TO ED ON 11/8 WITH COMPLAINTS OF SOB AND PRODUCTIVE COUGH AND TESTED POSITIVE.  PATIENT WAS GIVEN DEXAMETHASONE AND REMDESIVIR, STEROID INHALER ADDED, AND UP TO 2L NC 02 SUPPORT PROVIDED FOR COPD EXCERBATION/COVID PNEUMONIA. PATIENT IMPROVED AND WAS DISCHARGED HOME.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  PATIENT WAS IMMUNIZED IN TIMELY MANNER WITH PFIZER MRNA VACCINE ON 2/28 AND 3/21 RESPECTIVELY.  PATIENT PRESENTED TO ED ON 11/8 WITH COMPLAINTS OF SOB AND PRODUCTIVE COUGH AND TESTED POSITIVE.  PATIENT WAS GIVEN DEXAMETHASONE AND REMDESIVIR, STEROID INHALER ADDED, AND UP TO 2L NC 02 SUPPORT PROVIDED FOR COPD EXCERBATION/COVID PNEUMONIA. PATIENT IMPROVED AND WAS DISCHARGED HOME.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Dizziness, SARS-CoV-2 test positive
Clinical narrative: Narrative:   PATIENT WAS IMMUNIZED IN A TIMELY MANNER 1/15 AND 2/5 RESPECTIVELY WITH PFIZER MRNA VACCINE. PATIENT TESTED POSITIVE AT OUTSIDE FACILITY 9-17, AND CAME TO FACILITY 9-24 WITH WORSENING DIZZINESS AND WEAKNESS. PT RECEIVED SUPPLEMENTAL O2 DURING HOSPITALIZATION, TREATED WITH REMDESIVIR, HE RECOVERED AND WAS LATER DISCHARGED.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Decreased appetite, Dehydration, Diarrhoea, Fatigue
Clinical narrative: Narrative:  Patient was immunized in timely manner x 3 with pfizer mrna vaccine--booster on 9-9. Patient presented to ED with complaints of diarrhea causing painful rash and fatigue. Predominant COVID sx included fatigue, diarrhea, and anorexia causing dehydration. Patient received monoclonal abs as the only covid treatment--no O2 support needed. Patient developed pseudomonas UTI requiring 2 week course of abx in facility. Patient was treated for these complications, improved and was discharged home after a lengthy hospital stay
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Rash, SARS-CoV-2 test positive, Urinary tract infection pseudomonal
Clinical narrative: Narrative:  Patient was immunized in timely manner x 3 with pfizer mrna vaccine--booster on 9-9. Patient presented to ED with complaints of diarrhea causing painful rash and fatigue. Predominant COVID sx included fatigue, diarrhea, and anorexia causing dehydration. Patient received monoclonal abs as the only covid treatment--no O2 support needed. Patient developed pseudomonas UTI requiring 2 week course of abx in facility. Patient was treated for these complications, improved and was discharged home after a lengthy hospital stay
Age: 72.0
Sex: M
Vaccine: FLUX, VARZOS
Symptoms: Unevaluable event
Clinical narrative: Narrative:  Patient was seen in emergency department after vaccines were administered and was sent home with prednisone 60 mg po daily for 5 days.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Fatigue, Malaise, SARS-CoV-2 test positive
Clinical narrative: Narrative:  PATIENT WAS IMMUNIZED IN A TIMELY MANNER WITH PFIZER MRNA VACCINE ON 1-30 AND 2-20-21 RESPECTIVELY.  PATIENT PRESENTED TO THE ED 11-5-21 WITH SOB AND FATIGUE AFTER TESTING POSITIVE OUTSIDE OF THE FACILITY ON 11-1-21. PT REQUIRED 02 SUPPORT AND RECIEVED REMDESIVIR, DEXAMETHASONE AND BARICITINIB TREATMENT. PT WAS TREATED, IMPROVED AND DISCHARGED WITH OXYGEN
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Fall, SARS-CoV-2 test positive
Clinical narrative: Narrative:  PT WAS VACCINATED IN A TIMELY MANNER 12/30/20, 1/20/21 AND PROVIDED BOOSTER 10/7/21 OF PFIZER MRNA VACCINE. PT CAME TO ED WITH COMPLAINTS OF WEAKNESS AFTER FALLING. PATIENT TESTED POSITIVE FOR COVID. HE WAS ADMITTED FOR WEAKNESS. PATIENT WAS TREATED, RECOVERED , AND DISCHARGED AFTER SHORT HOSPITAL STAY.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Muscular weakness, SARS-CoV-2 test positive
Clinical narrative: Narrative: WAS VACCINATED IN TIMELY MANNER 2/9/21 AND 3/1/21 WITH PFIZER MRNA VACCINE. PRESENTED TO ED WITH WITH LE WEAKNESS. HE WAS TESTED FOR COVID UPON ADMIT AND HAD A POSITVE CEPHEID. RECEIVED MONOCLONAL ABS, BUT REMAINDER OF HOSPITAL STAY WAS RELATIVELY UNREMARKABLE FOR COVID.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Hypoxia, Productive cough, SARS-CoV-2 test positive
Clinical narrative: Narrative:  PATIENT WAS VACCINATED WITH JANSSEN 3-14-21. ON 9/24 PATIENT TESTED POSITIVE CALLING WITH C/O PRODUCTIVE COUGH AND SOB AT REST. PATIENT CAME TO ER AND WAS ADMITTED FOR HYPOXIA. HE HAD A 10 DAY HOSPITAL STAY REQUIRING UP TO 6L OF SUPPLEMENTAL O2. PATIENT WAS TREAT, RECOVERED AND DISCHARGED HOME.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, Computerised tomogram head abnormal, Intracranial mass, Micturition urgency, Personality change
Clinical narrative: Narrative: PT PRESENTED TO ED WITH COMPLAINTS OF URINARY URGENCY AND FAMILY NOTED SIGNIFICANT PERSONALITY CHANGES OVER THE LAST FEW WEEKS. CT FOUND A LARGE FRONTAL LOBE MASS. PT WAS ADMITTED FOR FURTHER TESTING AND TESTED FOR COVID AS A PRECAUTIONARY MEASURE. HE TESTED POSITIVE, REMAINED ASYMPTOMATIC DURING HOSPITAL STAY, REQUIRED NO COVID TX OR 02 SUPPORT. PT WAS TREATED FOR NON-COVID  RELATED ISSUES AND WAS LATER DISCHARGED HOME.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: PT PRESENTED TO ED WITH COMPLAINTS OF URINARY URGENCY AND FAMILY NOTED SIGNIFICANT PERSONALITY CHANGES OVER THE LAST FEW WEEKS. CT FOUND A LARGE FRONTAL LOBE MASS. PT WAS ADMITTED FOR FURTHER TESTING AND TESTED FOR COVID AS A PRECAUTIONARY MEASURE. HE TESTED POSITIVE, REMAINED ASYMPTOMATIC DURING HOSPITAL STAY, REQUIRED NO COVID TX OR 02 SUPPORT. PT WAS TREATED FOR NON-COVID  RELATED ISSUES AND WAS LATER DISCHARGED HOME.
Age: 103.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 102 yo male died
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Diabetic ketoacidosis, SARS-CoV-2 test positive
Clinical narrative: Narrative:  PATIENT WAS VACCINATED IN TIMELY MANNER 3/19 AND 4/10 RESPECTIVELY WITH PFIZER MRNA VACCINE. PATIENT PRESENTED TO ED 11/4 WITH DKA AND WAS FOUND TO BE COVID POSITIVE. HE WAS ADMITTED FOR DKA LIKELY COMPLICATED BY COVID, BUT OTHER THAN TX WITH CAS/IMDE MAB, PT REQUIRED NO 02 OR OTHER COVID TREATMENT.  PATIENT WAS TREATED, RECOVERED. AND DISCHARGED TO HOME.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Injection site discomfort, Vision blurred
Clinical narrative: Narrative:  Patient contacted telephone triage nurse today requesting to speak with PCP clinic. States he had a COVID BOOSTER SHOT 2 days ago, "I think I'm having some issues and I want to talk to my doctor." Patient states he felt okay the day he received the injection he felt fine, "But I woke up the next day and I'm so tired." States he has had fatigue and some very mild blurred vision ever since. No worse today than he was yesterday, "just wanted to make sure I'm not having some sort of reaction." Patient is otherwise asymptomatic. Still able to perform ADL's without difficulty. Some mild discomfort at injection site, R deltoid, "the site looks great, no redness or anything, healing well."
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Inflammatory marker test, International normalised ratio normal, Laboratory test normal, Pain
Clinical narrative: Narrative: 74-year-old with a PMH of HTN, skin cancer, and DVT reported joint pain after receiving the second dose of COVID 19 Vaccine to his  outpatient clinic. Per telephone triage note, the patient went to an outside hospital's ED and received Methylprednisolone; however, he still experienced body pain. Thus, the pharmacist ordered inflammatory marker labs, CHEM-8 and INR. All labs were within normal limit. The patient was then seen by his provider and given naproxen 500 mg to help with the body pain.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  PATIENT WAS IMMUNIZED IN A TIMELY MANNER WITH PFIZER MRNA VACCINE 4/21/21 AND 5/12 RESPECTIVELY. PATIENT WAS INPATIENT FOR STROKE REHAB WHEN HE CONTRACTED COVID. HE DECLINED MOST COVID TREATMENTS AND DID NOT QUALIFY FOR MONOCLONAL ABS. HE RECEIVED 02 SUPPORT UP TO 3L NC. WITH TIME, HE IMPROVED AND WAS TRANSFERED BACK FOR FURTHER REHABILITATION
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Decreased appetite, Physical deconditioning, Polyuria
Clinical narrative: Narrative:  Patient was hospitalized in timely manner with Pfizer mrna vaccine on 2-19-21 and 3-15-21 respectively at a non-facility site. Pt presented to ED 11-9-21 with polyuria, weakness and poor appetite. He tested positive for COVID at a non facility provider 11-1.  Patient had a positive biofire on 11-9. He remained hospitalized due to weakness--patient never required O2 support or any COVID treatments. He was later transferred for rehabilitation due to deconditioning related to COVID weakness and later discharged home.  Patient has history of DLBCL but has been in remission since 2018--not likely related to COVID
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient was hospitalized in timely manner with Pfizer mrna vaccine on 2-19-21 and 3-15-21 respectively at a non-facility site. Pt presented to ED 11-9-21 with polyuria, weakness and poor appetite. He tested positive for COVID at a non facility provider 11-1.  Patient had a positive biofire on 11-9. He remained hospitalized due to weakness--patient never required O2 support or any COVID treatments. He was later transferred for rehabilitation due to deconditioning related to COVID weakness and later discharged home.  Patient has history of DLBCL but has been in remission since 2018--not likely related to COVID
Age: 75.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Narrative:  pt developed rash after receiving the recombinant zoster vaccine
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: time course) and treatment, if any:   Narrative:
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity, Rash, Rash pruritic
Clinical narrative: Narrative:  Presents approximately 2.5 months after first and second Materna  injection of which patient had severe rash bilateral arms. Provided referral today with evidence of SEVERE reaction. steroids essentially ineffective parenterally, dermatology indicating immediate allergic reaction one day after first vaccine and informed "will have to run it's course and improve". taking once daily antihistamine and topical steroids. remains mildly pruritic.and now evident as scattered rash bilat forearms.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/11, Pfizer, dose #1 03/04, Pfizer, dose #2 12/30 COVID swab, result: detected 12/24 pt cc: exposure: unknown
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardiac disorder, Chest X-ray abnormal, Cough, Laboratory test
Clinical narrative: Narrative: COVID infection following COVID vaccine series unknown date and location. Pt had Pfizer vaccines. 12/24 SARS-COV-2 Variant Sequencing: pending 12/24 COVID swab, result: detected 12/24 pt admit cc: mild cough/runny nose dx: COVID 19 INFECTION LOS: 1 day 12/24 CXR impression: Lungs: Mild faint hazy opacity in the right medial lower lung zone which may represent early infectious or inflammatory process including COVID. Cardiomediastinal silhouette: No enlargement of the cardiomediastinal silhouette. Bones and soft tissues: Degenerative changes of the spine. 12/24 pt cc: cough exposure: unknown
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Lung opacity, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series unknown date and location. Pt had Pfizer vaccines. 12/24 SARS-COV-2 Variant Sequencing: pending 12/24 COVID swab, result: detected 12/24 pt admit cc: mild cough/runny nose dx: COVID 19 INFECTION LOS: 1 day 12/24 CXR impression: Lungs: Mild faint hazy opacity in the right medial lower lung zone which may represent early infectious or inflammatory process including COVID. Cardiomediastinal silhouette: No enlargement of the cardiomediastinal silhouette. Bones and soft tissues: Degenerative changes of the spine. 12/24 pt cc: cough exposure: unknown
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Dyspnoea, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/21, Pfizer, dose #1 02/10, Pfizer, dose #2 09/10, Pfizer, dose #3 12/24 COVID swab, result: detected 12/22 pt cc: diarrhea, fatigue, dyspnea, rhinorrhea exposure: unknown 12/24 SARS-COV-2 Variant Sequencing: pending 12/24 pt admit to ED cc: "I have cough, runny nose, sore throat and body aches" dx: Coronavirus - 19 LOS: 1day 12/29 clinically resolved
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test, Oropharyngeal pain, Pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/21, Pfizer, dose #1 02/10, Pfizer, dose #2 09/10, Pfizer, dose #3 12/24 COVID swab, result: detected 12/22 pt cc: diarrhea, fatigue, dyspnea, rhinorrhea exposure: unknown 12/24 SARS-COV-2 Variant Sequencing: pending 12/24 pt admit to ED cc: "I have cough, runny nose, sore throat and body aches" dx: Coronavirus - 19 LOS: 1day 12/29 clinically resolved
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Myalgia, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/12, Pfizer, dose #1 04/09, Pfizer, dose #2 12/24 COVID swab, result: detected 12/24 pt cc: sore throat, myalgias, sore throat, rhinorrhea and a dry, non-productive cough. exposure: unknown 12/24 SARS-COV-2 Variant Sequencing: pending 12/24 pt admit ED cc: sore throat, myalgias, sore throat, rhinorrhea and a dry, non-productive cough dx: Covid-19 LOS: 1 day
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/12, Pfizer, dose #1 04/09, Pfizer, dose #2 12/24 COVID swab, result: detected 12/24 pt cc: sore throat, myalgias, sore throat, rhinorrhea and a dry, non-productive cough. exposure: unknown 12/24 SARS-COV-2 Variant Sequencing: pending 12/24 pt admit ED cc: sore throat, myalgias, sore throat, rhinorrhea and a dry, non-productive cough dx: Covid-19 LOS: 1 day
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Blood bicarbonate increased, Blood pH normal, Brain natriuretic peptide normal, COVID-19, Cough
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/24, Pfizer,  dose #1 003/19, Pfizer, dose #2 10/01,Pfizer, dose #3 12/24 SARS-COV-2  Variant Sequencing: pending 12/24 COVID swab, result: detected 12/23 pt cc:  cough, fatigue, headache, myalgias, rhinorrhea, sore throat exposure: unknown  12/28 abg: i-pH: 7.44 i-PC02: 46.5, i-P02: 70, i-HC03: 31.7 12/28 BNP: 45  12/28 pt admit ED, cc: shortness of breath and worsening cough, dx: COVID Viral  Syndrome LOS: 1 dav 01/03/22 clinically resolved
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Headache, Inappropriate schedule of product administration, Myalgia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/24, Pfizer,  dose #1 003/19, Pfizer, dose #2 10/01,Pfizer, dose #3 12/24 SARS-COV-2  Variant Sequencing: pending 12/24 COVID swab, result: detected 12/23 pt cc:  cough, fatigue, headache, myalgias, rhinorrhea, sore throat exposure: unknown  12/28 abg: i-pH: 7.44 i-PC02: 46.5, i-P02: 70, i-HC03: 31.7 12/28 BNP: 45  12/28 pt admit ED, cc: shortness of breath and worsening cough, dx: COVID Viral  Syndrome LOS: 1 dav 01/03/22 clinically resolved
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, PCO2 increased, PO2 decreased, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/24, Pfizer,  dose #1 003/19, Pfizer, dose #2 10/01,Pfizer, dose #3 12/24 SARS-COV-2  Variant Sequencing: pending 12/24 COVID swab, result: detected 12/23 pt cc:  cough, fatigue, headache, myalgias, rhinorrhea, sore throat exposure: unknown  12/28 abg: i-pH: 7.44 i-PC02: 46.5, i-P02: 70, i-HC03: 31.7 12/28 BNP: 45  12/28 pt admit ED, cc: shortness of breath and worsening cough, dx: COVID Viral  Syndrome LOS: 1 dav 01/03/22 clinically resolved
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Incorrect dose administered, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 07/19, Pfizer, dose #1 08/09, Pfizer, dose #2 12/23 COVID swab, result: detected 12/23 pt cc: exposure: unknown 12/23 SARS-COV-2 Variant Sequencing: pending 1/06/22 COVID19 MONITR PANEL: pending
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Chills, Cough, Inappropriate schedule of product administration
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03 19, Pfizer,  dose #1 04/09, Pfizer, dose #2 11/26 CXR impression: No acute findings in the  chest 12/24 pt admit ED, cc: BODY ACHES, NASAL CONGESTION, dx:  VIRAL SYNDROME LOS: 1 day 12/24 SARS-COV-2 Variant Sequencing:  pending 12/24 COVID swab, result: detected 01/02 COVID swab, result: detected  01/04 COVID swab, result: detected 12/23 pt cc: chills, cough, fever, rhinorrhea  exposure: unknown 12/29 clinically resolved 01/07 COVID-19 MONITOR  PANEL: pending
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03 19, Pfizer,  dose #1 04/09, Pfizer, dose #2 11/26 CXR impression: No acute findings in the  chest 12/24 pt admit ED, cc: BODY ACHES, NASAL CONGESTION, dx:  VIRAL SYNDROME LOS: 1 day 12/24 SARS-COV-2 Variant Sequencing:  pending 12/24 COVID swab, result: detected 01/02 COVID swab, result: detected  01/04 COVID swab, result: detected 12/23 pt cc: chills, cough, fever, rhinorrhea  exposure: unknown 12/29 clinically resolved 01/07 COVID-19 MONITOR  PANEL: pending
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Viral infection
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03 19, Pfizer,  dose #1 04/09, Pfizer, dose #2 11/26 CXR impression: No acute findings in the  chest 12/24 pt admit ED, cc: BODY ACHES, NASAL CONGESTION, dx:  VIRAL SYNDROME LOS: 1 day 12/24 SARS-COV-2 Variant Sequencing:  pending 12/24 COVID swab, result: detected 01/02 COVID swab, result: detected  01/04 COVID swab, result: detected 12/23 pt cc: chills, cough, fever, rhinorrhea  exposure: unknown 12/29 clinically resolved 01/07 COVID-19 MONITOR  PANEL: pending
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Inappropriate schedule of product administration, Oropharyngeal pain
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/18, Pfizer, dose #1 04/08, Pfizer, dose #2 11/01, Pfizer, dose #3 COVID swab, result: detected 12/21 pt cc: cough and sore throat exposure: wife & daughter 12/23 pt admit to ED cc: " 2 days ago he has been with sore throat and nonproductive cough" dx: LOS: 1 day 12/23 SARS-COV-2 Variant Sequencing: pending 12/24 CXR impression: No acute cardiopulmonary disease.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/18, Pfizer, dose #1 04/08, Pfizer, dose #2 11/01, Pfizer, dose #3 COVID swab, result: detected 12/21 pt cc: cough and sore throat exposure: wife & daughter 12/23 pt admit to ED cc: " 2 days ago he has been with sore throat and nonproductive cough" dx: LOS: 1 day 12/23 SARS-COV-2 Variant Sequencing: pending 12/24 CXR impression: No acute cardiopulmonary disease.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Muscular weakness
Clinical narrative: Narrative: 73 yo male with PIVIH BPH, chronic backpain, dyslipidemia, osteopenia and migraine who reported bilateral leg weakness after receiving his second Moderna vaccine on 2/09/2021. Patient was then referred to neurology and pain specialists. Per note, they have not found the reason for his bilateral weakness. Unsure if it correlates to the vaccine. Per neurology recommendation, patient should try stopping atorvastatin for a short period. Of note, patient received the booster dose on December 10, 2021.